---
schema_version: "secwatch.filing_event.v1"
accession: "0001551986-23-000049"
form_type: "8-K"
ticker: null
cik: "0001551986"
company_name: "9 METERS BIOPHARMA, INC."
filed_at: "2023-06-16T23:59:59+00:00"
generated_at: "2026-06-13T22:37:49.298213+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# 9 Meters Biopharma receives Nasdaq non-compliance notice for bid price below $1.00

## Summary
- On June 12, 2023, Nasdaq notified 9 Meters that its stock closed below $1.00 for 31 consecutive business days.
- Company has 180 calendar days (until Dec 11, 2023) to regain compliance by closing at $1.00 or more for 10 consecutive days.
- If not cured, may be eligible for additional 180-day period if meeting other listing standards and provides notice.
- No immediate effect on listing; company is evaluating options to regain compliance.
- There is no assurance of regaining compliance; delisting risk remains.

## SEC filing metadata
- accession: 0001551986-23-000049
- form_type: 8-K
- cik: 0001551986
- company_name: 9 METERS BIOPHARMA, INC.
- filed_at: 2023-06-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551986/000155198623000049/0001551986-23-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551986/000155198623000049/nmtr-20230612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001551986-23-000049
- JSON: https://secwatch.observer/filing/0001551986-23-000049.json
- Plain text: https://secwatch.observer/filing/0001551986-23-000049.txt

## Key facts
- Listing & Compliance Notices
  9 METERS BIOPHARMA, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: June 12, 2023, 9 Meters Biopharma, Inc. (the “Company”) was notified by the Nasdaq Stock Market LLC (“Nasdaq”) that for the last 31 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until December 11, 2023, to regain compliance with the Bid Price Rule. If at any time before December 11
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551986/000155198623000049/0001551986-23-000049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.